Losing Weight is Hard, we Make it a Little Easier with Science
Mounjaro is a single molecule that activates glucose-dependent insulinotropic polypeptide (GIP) receptors and glucagon-like peptide-1 (GLP-1) receptors. GIP and GLP-1 are both natural incretin hormones. GIP has been shown to decrease how much you eat and increase your energy expenditure, which results in weight loss.
Monjouro currently, it is indicated for use in patients with type 2 diabetes, but it shows promise as a weight-loss drug as well. Clinical trials found doses of tripeptide can help assist with weight loss.